NSD2 通过将一碳代谢转向表观基因组驱动 t(4;14) 骨髓瘤细胞对腺苷酸激酶 2 的依赖
本文研究 t(4;14) 多发性骨髓瘤中 NSD2 过表达如何造成代谢脆弱性。全基因组 CRISPR 筛选发现腺苷酸激酶 2(AK2)是 NSD2 驱动的依赖点;NSD2 过表达大量增加染色质甲基化、耗竭 S-腺苷甲硫氨酸,损害肌酸合成,补充肌酸可恢复 NADP(H)、减少 DNA 损伤并挽救 AK2 缺陷细胞。AK2 缺失还损害内质网蛋白折叠,并增加骨髓瘤细胞对蛋白酶体抑制的敏感性。
要点
- 全基因组 CRISPR 筛选在骨髓瘤细胞中鉴定 AK2 为 NSD2 驱动的脆弱点。
- NSD2 过表达增加染色质甲基化、耗竭 S-腺苷甲硫氨酸,损害肌酸合成。
- 补充肌酸可恢复 NADP(H)、减少 DNA 损伤并挽救 AK2 缺陷的 t(4;14) 细胞。
核心结论
- NSD2 驱动的肌酸耗竭是 t(4;14) 骨髓瘤细胞对 AK2 缺失超敏的基础,碳流向表观基因组可造成代谢脆弱性并对 t(4;14) 骨髓瘤有直接治疗意义。
研究设计与样本
- 在骨髓瘤细胞中进行全基因组 CRISPR 筛选,并在 t(4;14) 骨髓瘤细胞中研究 AK2 抑制或缺失的效应。
主要发现
- t(4;14) 骨髓瘤细胞中抑制 AK2 降低用于核糖核苷酸转化为脱氧核糖核苷酸的 NADP(H),导致复制应激、DNA 损伤和凋亡。
- NSD2 过表达驱动染色质甲基化大幅增加,耗竭 S-腺苷甲硫氨酸,损害由胍基乙酸合成肌酸。
- 补充肌酸恢复 NADP(H) 水平、减少 DNA 损伤并挽救 AK2 缺陷的 t(4;14) 骨髓瘤细胞。
- t(4;14) 细胞中耗竭 AK2 损害内质网蛋白折叠,与线粒体 ATP 利用受损一致。
- 抑制 AK2 增加骨髓瘤细胞对蛋白酶体抑制的敏感性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chromosomal translocation (4;14), an adverse prognostic factor in multiple myeloma (MM), drives overexpression of the histone methyltransferase nuclear receptor binding SET domain protein 2 (NSD2). A genome-wide CRISPR screen in MM cells identified adenylate kinase 2 (AK2), an enzyme critical for high-energy phosphate transfer from the mitochondria, as an NSD2-driven vulnerability. AK2 suppression in t(4;14) MM cells decreased nicotinamide adenine dinucleotide phosphate (NADP[H]) critical for conversion of ribonucleotides to deoxyribonucleosides, leading to replication stress, DNA damage, and apoptosis. Driving a large genome-wide increase in chromatin methylation, NSD2 overexpression depletes S-adenosylmethionine, compromising the synthesis of creatine from its precursor, guanidinoacetate. Creatine supplementation restored NADP(H) levels, reduced DNA damage, and rescued AK2-deficient t(4;14) MM cells. As the creatine phosphate shuttle constitutes an alternative means for mitochondrial high-energy phosphate transport, these results indicate that NSD2-driven creatine depletion underlies the hypersensitivity of t(4;14) MM cells to AK2 loss. Furthermore, AK2 depletion in t(4;14) cells impaired protein folding in the endoplasmic reticulum, consistent with impaired use of mitochondrial adenosine triphosphate (ATP). Accordingly, AK2 suppression increased the sensitivity of MM cells to proteasome inhibition. These findings delineate a novel mechanism in which aberrant transfer of carbon to the epigenome creates a metabolic vulnerability, with direct therapeutic implications for t(4;14) MM.
引用
- Sobh A, Encinas E, Patel A, et al. NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome. Blood. 2024. PMID: 38598835. doi:10.1182/blood.2023022859
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。